Safety and Efficacy of HB-1 for Panic Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to determine the safety and efficacy of HB-1 versus placebo in male and female adult patients aged 18 to 60 years, inclusive, with Panic Disorder.
Epistemonikos ID: 66dd46f5ba586c007c087bca1a1b6f5759844978
First added on: May 09, 2024